137
Participants
Start Date
November 30, 2016
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
Oral Encochleated Amphotericin B (CAMB)
lipid-crystal nano-particle formulation amphotericin B
Fluconazole
ProHEALTH Care Associates, LLC - Suffolk OB-GYN, Port Jefferson
Tidewater Clinical Research, Inc., Norfolk
PMG Research of Salisbury, LLC., Salisbury
PMG Research of Wilmington, LLC, Wilmington
Brighton Clinical Research Associates, Norcross
Mt. Vernon Clinical Research - Wake Research, Atlanta
Neostart Corporation dba AGA Clinical Trials, Hialeah
Healthcare Clinical Data, Inc., North Miami
South Florida Medical Research, Aventura
Visions Clinical Research, Wellington
Altus Research, Lake Worth
Clinical Research of West Florida - Tampa, Tampa
Advanced Research Institute Inc, New Port Richey
Alabama Clinical Therapeutics, Birmingham
Jackson Clinic, Jackson
Complete Health Care for Women, Columbus
Study Center, Columbus
Medpharmics, Metairie
Clinical Trials of Texas, Inc., San Antonio
Precision Trials, LLC, Phoenix
National Research Institute - Wilshire, Los Angeles
New England Center for Clinical Research, Inc., Fall River
Lawrence OB/GYN, Lawrenceville
Matinas BioPharma Nanotechnologies, Inc.
INDUSTRY